4[1]Umekawa T,Yoshida T,Sakame N,et al.Anti-obesity and anti-diabetic effects of CL 316243, a highly specific β3-adrenoceptor agonist,in Otsuka Long-Evans Tokushima Fatty rats:induction of uncoupling protein and activation of glucose transporter 4 in white fat[J].Eur J Endocrinol,1997,136:429.
5[2]Fehmann HC,Peiser C,Bode Hp,et al.Leptin:a potent inhibitor of insulin secretion[J].Peptides,1997,18(8):1267-1273.
6[3]Krempler F,Hell E,Winkler C,et al.Plasma leptin levels:interaction of obesity with a common variant of insulin receptor substrate-l[J].Arterioscler Thromb Vasc Biol,1998,101:1354-1361.
7[4]Montague CT,Prins JB,Sanders L,et al:Depot-and sex-specific differences in human leptin mRNA expression[J].Implication for the control of regional fat distribution.Diabetes.1997,46:342-347.
8[5]Montague CI,Prins JB,Sanders I,et al.Depot-related gene expression in human subcutaneous and omental adipocytes[J].1998,47:1384-1391.
9[6]Lrgrnbre A-M,Laville M,Vega N,et al.Depot-specific differences in adipose tissue gene expression in lean and obese subjects[J].Diabetes 1998,47:98-103.
